First Real-World Data on Second-Generation AR Inhibitor Use in nmCRPC

Season 4 Episode 14  ·  Sep 18, 2023, 03:20 PM
Headliner
Share
Subscribe

Alicia Morgan, MD, MPH on real-world data from the DEAR study.

Share
Subscribe
Next
Desai on Embracing Curiosity and Change in the Oncology Field
Top episodes
Individualizing Immunotherapy in Non–Small Cell Lung Cancer
by Targeted Talks
The Importance of Trastuzumab Deruxtecan in HER2+ Breast Cancer Treatment
by Targeted Talks
Modern Strategies Improving Immunotherapy in Cancer
by Targeted Talks